iPath Pure Beta Softs ETN
GRWN
GRWN was delisted on the 3rd of April, 2018.
1 hedge funds and large institutions have $3K invested in iPath Pure Beta Softs ETN in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
25% less capital invested
Capital invested by funds: $4K → $3K (-$1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.93K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $3K | -$1.93K | -91 | -41% |
|
GRWN Hedge Fund Activity: Q4 2015 in Review
1 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Softs ETN (GRWN) for Q4 2015, worth a combined $3K — down 25% from $4K a quarter earlier.
Fund positioning in GRWN was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $1.93K.
- 1 institutional investor held iPath Pure Beta Softs ETN (GRWN) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $3K of iPath Pure Beta Softs ETN stock for Q4 2015, down 25% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Softs ETN positions in Q4 2015 and 0 closed out.
- The largest iPath Pure Beta Softs ETN seller in Q4 2015 was UBS Group, an estimated $1.93K sold.
Based on aggregated 13F filings for Q4 2015.